7-30026475-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_017946.4(FKBP14):āc.34C>Gā(p.Leu12Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000533 in 1,613,416 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_017946.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FKBP14 | NM_017946.4 | c.34C>G | p.Leu12Val | missense_variant | 1/4 | ENST00000222803.10 | NP_060416.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FKBP14 | ENST00000222803.10 | c.34C>G | p.Leu12Val | missense_variant | 1/4 | 1 | NM_017946.4 | ENSP00000222803.5 | ||
FKBP14 | ENST00000419018.1 | n.34C>G | non_coding_transcript_exon_variant | 1/3 | 1 | ENSP00000406270.1 | ||||
FKBP14 | ENST00000479939.1 | n.162C>G | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
FKBP14-AS1 | ENST00000422239.6 | n.1768G>C | non_coding_transcript_exon_variant | 4/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00289 AC: 440AN: 152216Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000805 AC: 202AN: 250950Hom.: 0 AF XY: 0.000575 AC XY: 78AN XY: 135698
GnomAD4 exome AF: 0.000286 AC: 418AN: 1461082Hom.: 3 Cov.: 31 AF XY: 0.000239 AC XY: 174AN XY: 726894
GnomAD4 genome AF: 0.00290 AC: 442AN: 152334Hom.: 2 Cov.: 33 AF XY: 0.00256 AC XY: 191AN XY: 74494
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2020 | - - |
Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at